Literature DB >> 28815283

Risk factors for recurrence after hysterectomy plus native-tissue repair as primary treatment for genital prolapse.

Stefano Manodoro1, Matteo Frigerio2,3, Alice Cola2,3, Federico Spelzini3,4, Rodolfo Milani2,3.   

Abstract

INTRODUCTION AND HYPOTHESIS: Identification of risk factors for pelvic organ prolapse (POP) recurrence is crucial to provide adequate preoperative counselling and tailor surgical treatment. The aim of this retrospective study was to identify risk factors for recurrence in a large series of patients with POP treated with primary transvaginal native-tissue repair involving high uterosacral ligament suspension.
METHODS: Postoperative descent of POP-Q stage 2 or higher in any compartment was considered as recurrence. Global recurrence (GR) was defined as any recurrence in any compartment irrespective of the surgical procedures performed during primary prolapse surgery. True recurrence (TR) was defined as recurrence in a compartment repaired during primary prolapse surgery.
RESULTS: Of a total of 533 eligible women, 519 were available for follow-up. Univariate analysis showed that age ≤50 years, premenopausal status, obesity (BMI >30 kg/m2), history of severe macrosomia (>4,500 g), preoperative POP stage 3 or higher and absence of anterior repair at the time of POP surgery were risk factors for GR. Multivariate analysis confirmed lack of posterior repair (odds ratio, OR, 1.8), severe macrosomia (OR 2.7), premenopausal status (OR 3.9), obesity (OR 2.2) and preoperative stage 3 or higher (OR  2.6) as risk factors for GR. Univariate analysis showed that premenopausal status and preoperative POP stage 3 or higher were risk factors for TR. Multivariate analysis confirmed premenopausal status (OR 4.0) and preoperative stage 3 or higher (OR 4.5) as risk factors for TR.
CONCLUSIONS: This study confirmed preoperative stage 3 or higher as a risk factor for prolapse recurrence. The study also identified additional risk factors for surgical failure including lack of posterior repair, severe macrosomia, premenopausal status and obesity.

Entities:  

Keywords:  Native-tissue repair; Pelvic organ prolapse; Recurrence; Risk factors

Mesh:

Year:  2017        PMID: 28815283     DOI: 10.1007/s00192-017-3448-7

Source DB:  PubMed          Journal:  Int Urogynecol J        ISSN: 0937-3462            Impact factor:   2.894


  22 in total

1.  Operation for pelvic organ prolapse: a follow-up study.

Authors:  Gunilla Tegerstedt; Margareta Hammarström
Journal:  Acta Obstet Gynecol Scand       Date:  2004-08       Impact factor: 3.636

2.  The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction.

Authors:  R C Bump; A Mattiasson; K Bø; L P Brubaker; J O DeLancey; P Klarskov; B L Shull; A R Smith
Journal:  Am J Obstet Gynecol       Date:  1996-07       Impact factor: 8.661

3.  An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic organ prolapse (POP).

Authors:  Bernard T Haylen; Christopher F Maher; Matthew D Barber; Sérgio Camargo; Vani Dandolu; Alex Digesu; Howard B Goldman; Martin Huser; Alfredo L Milani; Paul A Moran; Gabriel N Schaer; Mariëlla I J Withagen
Journal:  Int Urogynecol J       Date:  2016-04       Impact factor: 2.894

4.  Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence.

Authors:  A L Olsen; V J Smith; J O Bergstrom; J C Colling; A L Clark
Journal:  Obstet Gynecol       Date:  1997-04       Impact factor: 7.661

5.  Risk factors for the recurrence of pelvic organ prolapse after vaginal surgery: a review at 5 years after surgery.

Authors:  I Diez-Itza; I Aizpitarte; A Becerro
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2007-02-28

6.  Outcomes of Transvaginal High Uterosacral Ligaments Suspension: Over 500-Patient Single-Center Study.

Authors:  Rodolfo Milani; Matteo Frigerio; Alice Cola; Carlo Beretta; Federico Spelzini; Stefano Manodoro
Journal:  Female Pelvic Med Reconstr Surg       Date:  2018 Jan/Feb       Impact factor: 2.091

7.  A constipation scoring system to simplify evaluation and management of constipated patients.

Authors:  F Agachan; T Chen; J Pfeifer; P Reissman; S D Wexner
Journal:  Dis Colon Rectum       Date:  1996-06       Impact factor: 4.585

8.  Histologic and metabolic assessment in a cohort of patients with genital prolapse: preoperative stage and recurrence investigations.

Authors:  Stefano Manodoro; Federico Spelzini; Maria C Cesana; Matteo Frigerio; Daniele Maggioni; Cecilia Ceresa; Cristina Penati; Martina Sicuri; Robert Fruscio; Gabriella Nicolini; Rodolfo Milani
Journal:  Minerva Ginecol       Date:  2016-09-21

9.  Effect of weight change on natural history of pelvic organ prolapse.

Authors:  Bela I Kudish; Cheryl B Iglesia; Robert J Sokol; Barbara Cochrane; Holly E Richter; Joseph Larson; Susan L Hendrix; Barbara V Howard
Journal:  Obstet Gynecol       Date:  2009-01       Impact factor: 7.661

10.  Avulsion of puborectalis muscle and other risk factors for cystocele recurrence: a 2-year follow-up study.

Authors:  Mirjam Weemhoff; Tineke F M Vergeldt; Kim Notten; Jan Serroyen; Paul H N M Kampschoer; Frans J M E Roumen
Journal:  Int Urogynecol J       Date:  2011-08-06       Impact factor: 2.894

View more
  10 in total

1.  Back to the future: vaginal hysterectomy and Campbell uterosacral ligaments suspension for urogenital prolapse.

Authors:  Caroline Pettenati; Florence Cour; Pierre-Olivier Bosset; Titouan Kennel; Adrien Vidart; Thierry Lebret
Journal:  Int Urogynecol J       Date:  2021-02-23       Impact factor: 2.894

2.  Anatomical outcomes 1 year after pelvic organ prolapse surgery in patients with and without a uterus at a high risk of recurrence: a randomised controlled trial comparing laparoscopic sacrocolpopexy/cervicopexy and anterior vaginal mesh.

Authors:  Eduardo Bataller; Cristina Ros; Sonia Anglès; Miriam Gallego; Montserrat Espuña-Pons; Francisco Carmona
Journal:  Int Urogynecol J       Date:  2018-07-09       Impact factor: 2.894

3.  LeFort colpocleisis for recurrent pelvic organ prolapse.

Authors:  Xiaojuan Wang; Changdong Hu; Yisong Chen; Keqin Hua
Journal:  Int Urogynecol J       Date:  2019-05-08       Impact factor: 2.894

4.  Pelvic pain after laparoscopic lateral suspension for pelvic organ prolapse: an unrecognized problem?

Authors:  Matteo Frigerio; Marta Barba; Alice Cola; Giuseppe Marino; Silvia Volontè; Tomaso Melocchi; Desirèe De Vicari; Paolo Passoni
Journal:  Int Urogynecol J       Date:  2022-10-07       Impact factor: 1.932

5.  Transvaginal levator myorrhaphy for posthysterectomy vaginal vault prolapse repair.

Authors:  Rodolfo Milani; Stefano Manodoro; Alice Cola; Stefania Palmieri; Matteo Frigerio
Journal:  Int Urogynecol J       Date:  2017-12-14       Impact factor: 2.894

6.  Surgical management of bladder erosion and pelvic pain after laparoscopic lateral suspension for pelvic organ prolapse.

Authors:  Rodolfo Milani; Stefano Manodoro; Paolo Passoni; Luca Locatelli; Marta Barba; Matteo Frigerio
Journal:  Int Urogynecol J       Date:  2020-03-05       Impact factor: 2.894

7.  Body mass index influences the risk of reoperation after first-time surgery for pelvic organ prolapse. A Danish cohort study, 2010-2016.

Authors:  Vibeke Weltz; Rikke Guldberg; Michael Due Larsen; Gunnar Lose
Journal:  Int Urogynecol J       Date:  2020-08-11       Impact factor: 2.894

8.  Pelvic organ prolapse recurrence after apical prolapse repair: does obesity matter?

Authors:  Nina Durchfort Metcalfe; Lisa M Shandley; Marisa Rogers Young; Michelle Higgins; Chidimma Abanulo; Gina M Northington
Journal:  Int Urogynecol J       Date:  2021-05-03       Impact factor: 2.894

9.  The Application of a Multidimensional Prediction Model in the Recurrence of Female Pelvic Organ Prolapse after Surgery.

Authors:  Ruirui Zhang; Liming Wang; Yawei Shao
Journal:  Appl Bionics Biomech       Date:  2022-08-12       Impact factor: 1.664

10.  Native-tissue prolapse repair: Efficacy and adverse effects of uterosacral ligaments suspension at 10-year follow up.

Authors:  Alice Cola; Giuseppe Marino; Rodolfo Milani; Marta Barba; Silvia Volontè; Federico Spelzini; Stefano Manodoro; Matteo Frigerio
Journal:  Int J Gynaecol Obstet       Date:  2022-02-08       Impact factor: 4.447

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.